Markvicka Taunia

Avg. Two Year Performance

(69%) Avg. Purchase Return
(30%) Compound
(38%) Avg. Sale Return
(17%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return21%(2%)(5%)(58%)(69%)
Purchase Success Rate2 of 42 of 42 of 40 of 40 of 4
Average Sale Return(4%)(36%)(56%)(111%)(38%)
Sale Success Rate0 of 40 of 40 of 40 of 40 of 4

Cleveland BioLabs, Inc.

Diversified Services » Research Services

Chief Operating Officer, Director:

Holdings: 100.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Pacira Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

SVP, Chief Commercial Officer:

Holdings: 8.81K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Cormedix Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 37.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--